Quick search:
Content Search
Result Content Research
Result Content Research
1 RNA Cell Therapy for COVID-19 Related ARDS in Development
2 Diagnosis and management of acute respiratory distress syndrome
3 Pathogenic airway neutrophilia drives ARDS in Black patients with severe COVID-19 in case study
4 Cancer May Be an Independent Risk Factor for ARDS in Critically Ill Patients
5 COVID Grant Boosts Startup's Lung Therapy
6 Strength Seen in ARIDIS PHARMACT (ARDS): Can Its 10% Jump Turn into More Strength?
7 Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS
8 CEO Of Aqualung Therapeutics Corp., Joe G.N. Garcia MD, Named Invited Speaker at the First Annual Acute Respiratory Distress Syndrome Drug Development Summit
9 About 5 pc of Covid patients suffering from ARDS: Expert Says breathing exercises can help in
10 Acute Respiratory Distress Syndrome during the COVID-19 Pandemic
11 BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at ISCT 2021 New Orleans VIRTUAL Meeting
12 Extracorporeal membrane oxygenation (ECMO) for severe Covid & critically ill patients
13 Biomarkers for acute respiratory distress syndrome | JIR
14 Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non-Invasive Positive Pressure Ventilation
15 Medical Breakthrough: CRISPR Gene Editing Technology from MIT and Harvard Phase 3: Aridis Pharmaceuticals
16 Centhaquine Improved Shock Index, ARDS, MODS, Reduced Blood Lactate Levels, And 8.8% Absolute Reduction In 28-Day All-Cause Mortality
17 Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
18 Covid: Common diabetes drug may help treat lung inflammation
19 Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients
20 Citius Pharmaceuticals to Feature Updated Positive Interim Results of i-MSC Study During Poster Presentation at International Society for Cell and Gene Therapy
21 Prone positioning beneficial for severe ARDS in postpartum COVID-19 patients: BMJ case report
22 A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome
23 Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway
24 Probabilistic forecasts of COVID-19 deaths with the progression rate from pneumonia to ARDS: An open-data-based global study
25 Kiniksa Outlines Next Steps for the Development of Mavrilimumab
26 ECMO for COVID Patients Who Do Not Respond To Mechanical Ventilation: What is it and How it works
27 I Spy an Opportunistic Infection? | MedPage Today
28 DRDO Issues Instructions for Use of Anti-COVID-19 Drug to Treat Infected Patients | The Weather Channel
29 Statins Do Not Improve COVID-19 Outcomes, Study Shows
30 The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?
31 Aridis Pharmaceuticals Inc (ARDS) falls -0.8580% for June 11
32 COVID-19 vs Non-COVID-19 ARDS: Comparing Characteristics, Outcomes
33 Study identifies two distinct phenotypes of COVID-19-associated ARDS
34 Aridis Pharmaceuticals Inc (ARDS) falls -0.9920% for June 04
35 Your Immune System Could Turn COVID-19 Deadly | UC San Francisco
36 Acute Respiratory Distress Syndrome (ARDS) Epidemiology
37 NI's first solar-powered compacting bins appear in Ards and North Down
38 Global Acute Respiratory Distress Syndrome (ARDS) Epidemiology Forecast to 2030
39 NHL Matchbox: Down sign off league campaign with big win over Meath
40 Four Little Flowers: Candle firm created in memory of baby son burns bright in Ards
41 Obesity, Inflammatory and Thrombotic Markers, and Major Clinical Outcomes in Critically Ill Patients with COVID-19 in the US
42 New solar-powered compacting bins installed in Ards and North Down
43 Visakhapatnam: Complex surgery gives new lease of life to a child
44 Global Acute Respiratory Distress Syndrome (ARDS) Market Size, Share & Trends Analysis Report 2021-2027 – Clark County Blog
45 Police concerned about welfare of missing Ards man Raymond Allen
46 How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
47 Measuring Mortality in ARDS: Mechanical Power vs Ventilatory Variables
48 Pathophysiology of COVID-19-associated acute respiratory distress syndrome
49 Fewer fungi types in lungs associated with more severe ARDS
50 Health Canada Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome
51 Long Term Decreased Exercise Capacity of COVID-19 Patients Who Received Mechanical Ventilation in Japan: A Case Series
52 Management of ARDS due to COVID-19 infection
53 COVID-19-Associated ARDS Can Be Treated With Extracorporeal Membrane Oxygenation
54 Cytokine adsorption during ECMO for COVID-19-related ARDS
55 Two distinct types of COVID-19-associated acute respiratory distress syndrome identified
56 Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
57 Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial
58 Deep Learning Algorithm Detects Acute Respiratory Distress Syndrome with Expert-Level Accuracy
59 Effect of PEEP in COVID-19-Related ARDS Similar to Classical ARDS
60 The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID-19 viruses
61 Metformin prevents pulmonary or lung inflammation in animals infected with SARS-CoV-2
62 Desidustat prevents development of ARDS in Phase II COVID-19 trial…
63 Incyte's Covid-19 associated ARDS study fails to meet primary endpoint
64 COVID-Related ARDS May Not Be So Different After All: An ICU Physician's View of What
65 BrainStorm's Covid-19 ARDS treatment improves lung function in study
66 Evaluation of PEEP and prone positioning in early COVID-19 ARDS
67 Remestemcel-L Fast Tracked for ARDS Due to COVID-19
68 Acticor recruits first patient in Covid-19 related ARDS treatment trial
69 Managing Critically Ill Patients with COVID-19, Acute Respiratory Distress Syndrome
70 Yale team demonstrates innovative approach towards long-duration energy storage solution | Yale West Campus
71 Natural products show promise against COVID-19 via iron chelation
72 Malseed not building up Tokyo hopes after surprise debut
73 Endothelial tissue injury significantly contributes to ARDS in COVID-19 patients, finds study
74 Acute Respiratory Distress Syndrome (ARDS): Overview and More
75 2020 Insights into the Acute Respiratory Distress Syndrome Market to 2030
76 Remestemcel-L reduces ARDS mortality in those under 65 years old
77 Effect of Prone Positioning on Intensity of Inspiratory Effort in ARDS
78 Acute Respiratory Distress Syndrome (ARDS) Epidemiology and
79 Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
80 Severe COVID-19 With ARDS in a Sickle Cell Disease Patient
81 Citius Pharmaceuticals Subsidiary NoveCite Announces Data from a Study of Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS")
82 FDA grants Fast Track designation to COVID-19 ARDS treatment
83 Opaganib shows promise in preventing ARDS-induced thrombosis
84 Lung mechanics and hypoxemia in COVID-19 patients with ARDS
85 FDA Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 Clinical Development in COVID-19 Patients
86 Deep learning to detect acute respiratory distress syndrome on chest radiographs: a retrospective study with external validation
87 ‘Early identification of symptoms in kids crucial for Cov treatment’
88 Researchers identify two distinct phenotypes of COVID-19-associated ARDS
89 ARDS-003 Eases Inflammation in PF Mice, Could Be COVID-19 Therapy
90 Immunosuppressive Drugs for Autoimmune Disease May Reduce Risk of ARDS in COVID-19 Hospitalizations
91 Studying a Surfactant Therapy for ARDS and COVID-19 Lung Injury
92 Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients
93 Results of Biomarck Phase II Study of BIO-11006 in Patients with ARDS to be Presented at the 2021 ATS Annual Meeting
94 Strategies to increase utilization of prone positioning for severe ARDS with COVID-19
95 Study finds link between low fungi diversity and severity of ARDS
96 COVID-19 and ARDS Educational Webinar: Recovery and Life After the ICU
97 CohBar Confirms Efficacy of Novel Apelin Agonists in Acute
98 Acute respiratory failure mortality increases in United States and may worsen with COVID-19 pandemic
99 Positive results for Cerecor's MAb in patients with COVID-19 ARDS
100 Stem cell therapy for COVID-19 and ARDS